Mounjaro Dosage Levels: What the Six Strengths Actually Mean

Six mg levels (2.5, 5, 7.5, 10, 12.5, 15) titrated in steps roughly four weeks apart, not all at once.
The lowest dose exists to reduce early side effects, not to drive weight loss; the therapeutic work happens at higher strengths.
Each pen format holds four weekly doses; the dose level is fixed per pen, so you start a new pen when you move up a rung.
Titration pace and ceiling are set by your prescriber based on tolerability and response, the schedule is not one-size-fits-all.

Mounjaro comes in six dosage levels — 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg — each supplied as a pre-filled KwikPen containing four weekly doses. The schedule is designed to be climbed gradually, letting your body adjust before the next step. These are prescription-only medicines; a GPhC-registered prescriber decides which strength is right for you and when to move up. Understanding how the levels work can help you have a more informed conversation with your clinical team.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the Mounjaro Dose Ladder Works in Practice

Why does Mounjaro start at 2.5mg if that's not the treatment dose?

The first pen's job is adjustment. At 2.5mg, the medicine is present at a level low enough to let your digestive system get used to the way tirzepatide slows gastric emptying and signals fullness through both GIP and GLP-1 receptors. Nausea and gut discomfort are most likely in the early weeks; starting low keeps those effects manageable for most people. The NHS medicines page for tirzepatide describes this starter phase clearly and is worth reading before your first pen arrives.

After four weeks, the prescriber reviews how you've tolerated things. If all is well, you move to 5mg. That pattern (four weeks at each level, then a clinical review before going further) continues up the ladder. Skipping steps is not something you can do yourself; it's a decision made with your prescriber based on your individual response, and for good reason. Pushing too fast typically means more side effects, not faster results.

One practical check worth building into your routine: before you start each new pen, you can read up on Mounjaro pens and dosage so you know exactly what strength to expect on the label and can catch any dispensing mix-up before the first injection. Small habit, real value.

What happens at the higher Mounjaro mg levels?

As the dose increases, so does the clinical effect. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that participants taking tirzepatide 15mg lost an average of around 20–21% of body weight over 72 weeks, with some analyses putting that figure higher. Those results come from the higher mg levels, not from 2.5mg or 5mg alone. Reaching the maximum dose of Mounjaro is the goal for many people, though not everyone needs to get there to see meaningful results.

The intermediate levels (7.5mg, 10mg, and 12.5mg) are not simply waypoints to rush through. Some people find a dose that works well for them and stays there, particularly if they are losing weight steadily and tolerating the medicine well. The ceiling of 15mg is the highest licensed strength in the UK; going beyond it is not an option and is not something any legitimate prescriber would offer. If you're curious about the full Mounjaro dosing schedule and what governs each step, that page goes into more detail on how titration decisions are made.

Do all six Mounjaro dose levels come as the same pen?

Each strength is its own pre-filled KwikPen, colour-coded and clearly labelled. The pen contains four doses of a fixed strength, so once you start a 7.5mg pen, every injection from that pen is 7.5mg. When you move to the next level, you open a new pen at the higher strength. This matters practically: you cannot dial up a dose mid-pen the way you would with some insulin devices.

The volume delivered per injection does change across the Mounjaro dose levels in millilitres, and some people want to understand exactly what they're injecting. That information is covered in the product's SmPC on the eMC, which is the most reliable place to check precise delivery volumes for each pen. For the purposes of using the pen correctly, the label strength is the figure that matters day to day.

Injection sites (abdomen, thigh, or upper arm) should be rotated regardless of which dose level you're on. Storage requirements are the same across all strengths: refrigerated between 2°C and 8°C, with a limited room-temperature window set out in the Patient Information Leaflet. NICE's appraisal of tirzepatide (TA1026) covers the clinical evidence base that underpins the licensed dose range, and reading its summary gives useful context on why this particular ladder was chosen.

How does a prescriber decide which Mounjaro dose level is right for me?

The short answer: they look at the whole picture, not just the number on the scale. Tolerability matters enormously. A prescriber who sees that you spent four weeks at 5mg feeling well and losing weight steadily will typically recommend moving up. One who hears about persistent nausea or significant gut disruption may suggest staying at the current level for another month before any increase. The prescriber's role is to find the highest dose that is effective for you without making daily life unpleasant.

At nume, every dose increase is reviewed clinically before a new pen is dispatched. That means providing evidence of your current weight and answering questions about how you've been tolerating things, a real prescriber reads your responses, not automated software. If you're considering treatment and want to understand more about the private route and what's assessed, starting a free consultation is the natural next step. Our clinical team, including our lead prescriber, reviews every case personally. There's also useful background on weight-loss treatment options more broadly if you're still weighing things up. Questions about cost sit separately, the Mounjaro pricing page explains what's included in a private prescription. And if the concept of a so-called "golden dose" has come up in your research, this page on whether the golden dose is safe covers what the evidence actually says.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions